CNN’s Elizabeth Cohen spoke with with Dawn Baker, the first person in the US to get a shot of Moderna’s investigational vaccine in a Phase 3 trial. Moderna is developing it with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
![](http://feeds.feedburner.com/~r/rss/cnn_topstories/~4/6O0dMV3AHu8)
Source: cnn news